MAUDE Adverse Event Report: MEDTRONIC, INC. MEDTRONIC LEAD; IMPLANTABLE PACEMAKER PULSE-GENERATOR

Model Number MDT-LEAD

Device Problems Break (1069); Failure to Capture (1081); Inappropriate/Inadequate Shock/Stimulation (1574); Device Sensing Problem (2917); Device Dislodged or Dislocated (2923)

Patient Problems Arrhythmia (1721); Chest Pain (1776); Dyspnea (1816); Undesired Nerve Stimulation (1980); Shock from Patient Lead(s) (3162); Presyncope (4410); Syncope/Fainting (4411)

Event Date 04/20/2022

Event Type  Injury  

Manufacturer Narrative

This information is based entirely on journal literature.Medtronic was made aware of this event through a search of literature publications.This event occurred outside the us.Patient information is limited due to confidentiality concerns.Select patient information cannot be included in regulatory report due to regional privacy regulations.Of note, multiple patients and multiple manufacturers were noted in the article; however, a one-to-one correlation could not be made with unique product serial/lot numbers.The model listed in the report is a representative of the model family, as there is no specific model listed.Without a lot number or device serial number, the manufacturing date cannot be determined.Since no device id was provided, it is unknown if this event has been previously reported.Referenced article: should we check it? assessing interrogation of cardiac implantable electronic devices in the emergency department¿the check-ed study: implications for service planning and care delivery.Heart, lung and circulation.2022.31, 1119¿1125.Doi: 10.1016/j.Hlc.2022.03.004 medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.

Event Description

Literature was reviewed regarding cardiovascular implantable electronic device (cied) interrogations in the emergency department (ed).All interrogations were requested by ed physicians and were from implantable cardioverter defibrillators (icds), implantable pulse generators (ipgs), and implantable cardiac monitors (icms).The purpose was to find remarkable issues which were defined as an arrhythmia with or without anti tachyarrhythmia therapy related to the ed presentation or a device-related issue requiring reprogramming or lead/device revision procedure.The authors described patients who presented with shock therapy, palpitations, chest pain, syncope, presyncope, or dyspnea.Some of the symptoms were due to programming issues.There were unknown device issues for all device types studied and lead issues included lead dysfunction for failure to capture due to damage or dislodgement, sensing failure, and phrenic capture due to left ventricular (lv) lead displacement.There was immediate intervention performed for battery depletion and lead dislodgement.The status of the devices and leads is unknown.No additional adverse patient effects or product performance issues were reported.

• Brand Name: MEDTRONIC LEAD
• Type of Device: IMPLANTABLE PACEMAKER PULSE-GENERATOR
• Manufacturer (Section D): MEDTRONIC, INC.; 8200 coral sea street ne; mounds view MN 55112
• Manufacturer (Section G): MEDTRONIC, INC.; 8200 coral sea street ne; mounds view MN 55112
• Manufacturer Contact: paula bixby ; 8200 coral sea st ne; mounds view, MN 55112 ; 7635055378
• MDR Report Key: 18360091
• MDR Text Key: 330913904
• Report Number: 2182208-2023-03760
• Device Sequence Number: 1
• Product Code: DXY
• Combination Product (y/n): N
• Reporter Country Code: AS
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Foreign,Literature
• Reporter Occupation: Other Health Care Professional
• Type of Report: Initial
• Report Date: 12/19/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 12/19/2023
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Lay User/Patient
• Device Model Number: MDT-LEAD
• Device Catalogue Number: MDT-LEAD
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Date Manufacturer Received: 12/07/2023
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Treatment: UNKNOWN COMPETITOR CIED
• Patient Outcome(s): Life Threatening; Hospitalization; Required Intervention
• Patient Sex: Male